[Changes of the cornea induced by lipopolysaccharide in Lewis rats]

A F de Vos1, A Kijlstra, P Yang

  • 1Zhongshan Ophthalmic Center, Sun Yat-sen University of Medical Sciences; National Ophthalmological Laboratory, Ministry of Public Health, Guangzhou, China.

Insights

Lipopolysaccharide (LPS) increases macrophages in the cornea, suggesting a defense mechanism. The cornea

Area of Science:

  • Ophthalmology
  • Immunology
  • Cell Biology

Context:

  • The cornea's immune privilege is crucial for maintaining vision.
  • Understanding immune cell dynamics in the cornea is vital for treating inflammatory conditions.

Purpose:

  • To investigate the corneal response to lipopolysaccharide (LPS) challenge.
  • To characterize the changes in immune cells, specifically macrophages and MHC class II-positive cells, within the cornea after LPS administration.

Summary:

  • Macrophages are present throughout the normal rat cornea, with density decreasing towards the center.
  • Lipopolysaccharide (LPS) injection significantly increases corneal monocytes and macrophages, altering their morphology.
  • Major histocompatibility complex class II (MHC class II)-positive cells were transiently observed on the corneal endothelium post-LPS, but absent in the normal cornea's stroma or epithelium.

Impact:

  • The influx of macrophages suggests a role in the corneal defense against LPS.
  • The limited expression of MHC class II antigens in the cornea may contribute to its immune-privileged status, maintaining tissue stability during inflammation.
Abstract

Related Concept Videos